Litcius/Paper detail

A randomized controlled trial of renin-angiotensin-aldosterone system inhibitor management in patients admitted in hospital with COVID-19

Abhinav Sharma, Malik Elharram, Jonathan Afilalo, Alexandria Flannery, Marc Afilalo, Chris Tselios, Jiayi Ni, Justin A. Ezekowitz, Matthew Pellan Cheng, Andrew P. Ambrosy, Faı̈ez Zannad, James M. Brophy, Nadia Giannetti, Amal Bessissow, Nadine Kronfli, Ariane Marelli, Haya Aziz, Mohammad Alqahtani, Mona Aflaki, Morgan Craig, Renato D. Lopes, João Pedro Ferreira

2022American Heart Journal22 citationsDOIOpen Access PDF

Topics & Concepts

DiscontinuationMedicineRandomized controlled trialInternal medicineLog-rank testAdverse effectSurvival analysisCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research
A randomized controlled trial of renin-angiotensin-aldosterone system inhibitor management in patients admitted in hospital with COVID-19 | Litcius